These tumor-suppressive effects occurred independently from functional ERα as well as of estrogens and were accompanied by notably increased mRNA levels of growth-inhibitory cyclin-dependent kinase inhibitor p21(WAF1) and a considerable reduction of cyclin A2 mRNA levels. This evidence concerns the gene CDKN1A and neoplasm.